16.03.2017 • News • agm • BASF • Dede Willams

Kreimeyer to Lead K+S Supervisory Board

(c) BASF
(c) BASF

Andreas Kreimeyer has been proposed to succeed Ralf Bethke as chairman of the supervisory board of  German minerals specialist K+S following the company’s annual general meeting (agm) in May. Bethke has served as chairman of the supervisory board since 2007, and prior to that was chairman of the managing board and CEO from 1991.

Kreimeyer, until 2015 a member of the BASF managing board with responsibility for R&D, took a seat on the K+S board the same year.

Thomas Kölbl, chief financial officer of German sugar producer Südzucker has been proposed for a seat on the K+S supervisory board following the agm. The other seats will remain unchanged

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Top-Feature

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.